Kessler Institute for Rehabilitation

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Pilot Study of Galantamine to Treat Metabolic Syndrome in People With Chronic Traumatic Spinal Cord Injury (SCI)	Insulin Resistance, Neurologic Manifestations, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, central nervous system disorder, glucose metabolism disease, hyperinsulinism, injury, metabolic disease, nervous system disorder, nervous system injury, palsy, paraplegia, quadriplegia, spinal cord disorder, spinal cord injury	Recruiting	Phase 2 / Phase 3	2026-06-04		NCT07625332
Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI	Bone Diseases, Metabolic, Nutritional and Metabolic Diseases, bone disorder, central nervous system disorder, injury, metabolic disease, musculoskeletal system disorder, nervous system disorder, nervous system injury, osteoporosis, spinal cord disorder, spinal cord injury	Active, not recruiting	Phase 4	2025-09-17		NCT05101018

Clinical trials